A rigorous 2026 UK evidence review covering the May 2025 UC Irvine Read the full review Neuroscience 22 May 2026 Dihexa for Tinnitus, Hyperacusis & Cochlear Synaptopathy: The 2026 UK Review Rigorous 2026 UK review of Dihexa for tinnitus, hyperacusis and cochlear synaptopathy (hidden hearing loss)
Regular monitoring helps ensure the frequency remains appropriate Once levels stabilise, injections are usually spaced further apart, often every few months
People deserve to know what they are putting into their bodies
They genuinely care and are always responsive and quick to help
By the time most patients notice visible changes in skin texture, hair density, or how quickly they recover from injury, the peptide that was quietly managing those processes has been declining for years
Knowing when to reduce dose or discontinue Not every side effect requires discontinuation, but some warrant reducing dose or stopping use